This study also has some limitations: (1) The original dataset of the current study did not contain information on the fasting insulin levels of the subjects, so we cannot further compare the risk assessment/predictive ability of the TyG index and TyG-related parameters with HOMA-IR for the future development of diabetes in the current study cohort. The gene discussed is INS; the disease is diabetes mellitus.